SMILE: a Scale-aware Multiple Instance Learning Method for Multicenter STAS Lung Cancer Histopathology Diagnosis
Liangrui Pan, Xiaoyu Li, Yutao Dou, Qiya Song, Jiadi Luo, Qingchun Liang, Shaoliang Peng · 2025
Read SMILE: a Scale-aware Multiple Instance Learning Method for Multicenter STAS Lung Cancer Histopathology Diagnosis by Liangrui Pan, Xiaoyu Li, Yutao Dou, Qiya Song, Jiadi Luo, Qingchun Liang, Shaoliang Peng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2503-13799.txt.
Introduction
A pattern called spread through air spaces marks lung cancers that behave aggressively, yet spotting it on slides is slow and varies between pathologists. Liangrui Pan and co-authors tackle the problem two ways at once. First they re-checked 2,970 slides from several hospitals and built three public datasets for this pattern. Then they propose SMILE, a learning method designed for whole-slide diagnosis.
Slides are far too big to feed to a model whole, so the method studies many small patches and weighs them by importance. A scale-aware attention step stops the model from fixating on a few local patches. SMILE beat the average clinical score on the test sets and set the first public baselines for this task. The authors release data and code to push the field forward.
Catalog record
| CREATOR | Liangrui Pan, Xiaoyu Li, Yutao Dou, Qiya Song, Jiadi Luo, Qingchun Liang, Shaoliang Peng |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2503-13799
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
SMILE: a Scale-aware Multiple Instance Learning Method for Multicenter STAS Lung Cancer Histopathology Diagnosis Liangrui Pan, Xiaoyu Li, Yutao Dou, Qiya Song, Jiadi Luo, Qingchun Liang, Shaoliang Peng Abstract Spread through air spaces (STAS) represents a newly identified aggressive pattern in lung cancer, which is known to be associated with adverse prognostic factors and complex pathological features. Pathologists currently rely on time-consuming manual assessments, which are highly subjective and prone to variation. This highlights the urgent need for automated and precise diagnostic solutions. 2,970 lung cancer tissue slides are comprised from multiple centers, re-diagnosed them, and constructed and publicly released three lung cancer STAS datasets: STAS_CSU (hospital), STAS_TCGA, and STAS_CPTAC. All STAS datasets provide corresponding pathological feature diagnoses and related clinical data. To address the bias, sparse and heterogeneous nature of STAS, we propose an scale-aware multiple instance learning(SMILE) method for STAS diagnosis of lung cancer. By introducing a scale-adaptive attention mechanism, the SMILE can adaptively adjust high-attention instances, reducing over-reliance on local regions and promoting consistent detection of STAS lesions. Extensive experiments show that SMILE achieved competitive diagnostic results on STAS_CSU, diagnosing 251 and 319 STAS samples in CPTAC and TCGA, respectively, surpassing clinical average AUC. The 11 open baseline results are the first to be established for STAS research, laying the foundation for the future expansion, interpretability, and clinical integration of computational pathology technologies. The datasets and code are available at https://anonymous.4open.science/r/IJCAI25-1DA1 . Figure 1: Three common pathological features of STAS in lung cancer histopathology images. STAS is mainly distributed outside the main tumor body in the form of solid cell nests, micropapillary clusters, and single cancer cells. 1 Introduction Spread Through Air Spaces (STAS) is recognized as a newly described invasive pattern in lung cancer. Onozato et al. Onozato et al. (2013) first noted tumor cells occupying alveolar spaces in 2013. The World Health Organization (WHO) later defined STAS as tumor cells (e.g., micropapillary clusters, solid nests, or single cells) that spread within air spaces beyond the main tumor Chae et al. (2021) . Using three-dimensional reconstruction, tumor islands initially appearing separate were found to be connected to the main tumor on different planes Warth et al. (2015) , implying an aggressive invasion mode correlated with higher tumor grade, KRAS mutations, and poorer recurrence-free survival. Numerous studies have shown that STAS frequently coexists with other high-risk pathological features, including pleural invasion, vascular invasion, larger tumor size, and higher stage, which collectively indicate a worse prognosis Eguchi et al. (2019) ; Shiono and Yanagawa (2016) . Histopathological images remain the gold standard for diagnosing STAS. Nevertheless, identification of STAS relies heavily on pathologists’ manual observation, leading to considerable subjectivity and dependence on individual expertise. The resultant workload can be overwhelming when processing large-scale slides, which risks both extended turnaround times and potential diagnostic inconsistencies. STAS status is also pivotal for surgical decision-making, such as choosing between lobectomy and sub-lobectomy, as intraoperative removal of STAS-affected regions improves patient survival Khalil et al. (2023) ; Zhou et al. (2022) . However, manual diagnostic approaches reportedly achieve about 74% accuracy (AUC = 0.67) Villalba et al. (2021) ; Wang et al. (2023) , underscoring the urgent need for more objective and efficient diagnostic methods. Artificial intelligence has shown tremendous promise in assisting pathological diagnoses, with notable successes in tumor classification, lesion boundary detection, and survival prediction. However, The diagnosis of STAS remains challenging. As an invasive pattern that has only recently been incorporated into pathology reports, STAS lacks a universally accepted diagnostic standard across clinical and pathology communities. This inconsistency leads to variations in diagnostic agreement and sensitivity among different institutions. Additionally, the availability of high-quality, multicenter annotated pathology datasets for STAS have not yet appeared, restricting the breadth and depth of related research. As illustrated in Figure 1 , STAS is characterized by tumor cell dissemination along the small airways, often presenting as scattered, minute lesions. These lesions vary in size, morphology, and exhibit significant heterogeneity, making comprehensive identification through conventional manual examination particularly difficult. Traditional pathological diagnostic approaches have inherent limitations in detecting STAS, especially in distinguishing subtle lesions and irregular morphological patterns, which can introduce diagnostic errors. Furthermore, accurate STAS assessment requires an in-depth understanding of tumor dissemination pathways within air spaces, further complicating the diagnostic process for pathologists. These challenges highlight the urgent need to refine diagnostic strategies to enhance the consistency, efficiency, and interpretability of STAS identification. To address the aforementioned challenges, we downloaded all lung cancer histopathological images from The Cancer Genome Atlas (TCGA) and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) projects. Three pathologists cross-diagnosed the STAS status and the types of dissemination foci for each slide, establishing the STAS_TCGA and STAS_CPTAC datasets. Importantly, we collected and curated histopathological images from STAS lung cancer patients at the Second Xiangya Hospital of Central South University and constructed the STAS_CSU dataset. Given the sparsity and heterogeneity of STAS pathological features, which typically appear as isolated cells or small clusters beyond the primary tumor body and are often difficult to detect in histopathological images, we propose SMILE, a novel scale-aware multiple instance learning method designed for STAS whole-slide image (WSI) classification. This approach introduces a scale-aware strategy to reduce the model’s over-reliance on high-attention instances, thereby enhancing its ability to capture sparse and heterogeneous features and improving STAS recognition accuracy. Our main contributions are as follows: • This study conducted STAS diagnosis on lung cancer patients from TCGA and CPTAC, and for the first time, constructed and publicly released three STAS datasets: STAS_CSU, STAS_TCGA, and STAS_CPTAC, comprising a total of 2,970 histopathological images. • We introduce a scale-adaptive attention mechanism that optimizes the SMILE to focus more evenly on instances in the bag by dynamically adjusting the attention to high-attention instances, thus improving the accuracy of STAS prediction in histopathology images. • We conduct benchmark evaluations of 11 multi-instance learning algorithms across Three STAS datasets, delivering comprehensive baseline results to advance research on STAS-assisted diagnosis. 2 Related Work 2.1 Lung Cancer Histopathology Image Datasets Currently, publicly accessible lung cancer histopathological image data mainly come from large-scale projects such as TCGA, CPTAC, and Cancer Digital Slide Archive (CDSA), as well as various datasets on the Kaggle platform Gutman et al. (2017) ; Borkowski et al. (2019) ; Heath et al. (2021) ; Lu et al. (2017) . The TCGA initiative provides WSIs and corresponding molecular data for both lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) via the Genomic Data Commons portal Han et al. (2021) . The CPTAC program offers digital pathology images for multiple cancer types, including lung cancer, while integrating proteomic data to facilitate multimodal research. On Kaggle, a well-known dataset titled “Lung and Colon Cancer Histopathological Images” includes hundreds of samples, 750 of which (250 benign lung tissue, 250 LUAD, and 250 LUSC) are labeled and suitable for classification or segmentation 1 1 1 https://www.kaggle.com/datasets/andrewmvd/lung-and-colon-cancer-histopathological-images . The CDSA also provides digital pathology slides; notably, the National Lung Screening Trial subset features 1,225 high-quality WSIs 2 2 2 https://cdas.cancer.gov/datasets/nlst/ . In addition, certain national cancer centers possess lung cancer histopathological datasets for domestic research, typically containing image, radiological, molecular, and clinical information. Although STAS has been repeatedly noted by the WHO as an invasive malignancy